Staging amyotrophic lateral sclerosis: A new focus on progression
- 31 December 2018
- journal article
- review article
- Published by Elsevier BV in Revue Neurologique
- Vol. 175 (5), 277-282
- https://doi.org/10.1016/j.neurol.2018.09.017
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Amyotrophic Lateral SclerosisNew England Journal of Medicine, 2017
- The phenotypic variability of amyotrophic lateral sclerosisNature Reviews Neurology, 2014
- Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating ScaleAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2014
- Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2014
- Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trialsJournal of Neurology, Neurosurgery & Psychiatry, 2014
- Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2013
- A proposed staging system for amyotrophic lateral sclerosisBrain, 2012
- Progression in ALS is not linear but is curvilinearZeitschrift für Neurologie, 2010
- Échelles fonctionnelles de la sclérose latérale amyotrophiqueRevue Neurologique, 2006
- Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALSNeurology, 2006